Market Tracker

09/02 10:04am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.51
Real-Time Quote
 +0.01 / +0.11%
Today’s Change
6.88
Today|||52-Week Range
18.18
-36.56%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close9.50
Today’s open9.53
Day’s range9.41 - 9.56
Volume67,435
Average volume (3 months)1,484,399
Market cap$1.2B
Dividend yield--
Data as of 9:49am ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+13.85%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-1.86-4.65%
NVAXNovavax Inc+0.13+2.77%
KITEKite Pharma Inc-0.56-1.98%
OPHTOphthotech Corp-0.46-1.18%
Data as of 10:03am ET, 09/02/2014

Financials

Next reporting dateNovember 7, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts